Recent Advances in Medical Technologies and Therapies: Stryker's innovative spine surgery technology receives FDA approval, OneMedNet raises $4.6 million in private funding, and the CHMP endorses RYBREVANT® (amivantamab) combined with chemotherapy for advanced EGFR-mutated NSCLC post-therapy failure.

Innovations in Healthcare: Stryker's FDA Approval, OneMedNet's Funding, and CHMP's Nod to RYBREVANT

Welcome to "The Weekly Snapshot - Medtech," your guide to the cutting-edge world of medical technology. Each week, we explore the latest innovations, uncover breakthroughs in healthcare, and dive into the trends shaping the future of medicine. Our host, a knowledgeable expert in the field, simplifies the complexities of medical technology, offering insights that cater to both industry professionals and curious minds. Whether you're fascinated by AI in diagnostics, the latest wearables, or revolutionary treatments, this podcast brings you a comprehensive view of the medtech landscape. Stay informed on the latest advances and developments, one snapshot at a time.

Share Innovations in Healthcare: Stryker's FDA Approval, OneMedNet's Funding, and CHMP's Nod to RYBREVANT

Sign up to save your podcasts

Innovations in Healthcare: Stryker's FDA Approval, OneMedNet's Funding, and CHMP's Nod to RYBREVANT

Innovations in Healthcare: Stryker's FDA Approval, OneMedNet's Funding, and CHMP's Nod to RYBREVANT